{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:19:06Z","timestamp":1773181146336,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.ejpb.2011.05.009","type":"journal-article","created":{"date-parts":[[2011,6,5]],"date-time":"2011-06-05T00:09:55Z","timestamp":1307232595000},"page":"126-134","source":"Crossref","is-referenced-by-count":54,"title":["A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate"],"prefix":"10.1016","volume":"79","author":[{"given":"Zengrong","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiancheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2011.05.009_b0005","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.addr.2007.05.006","article-title":"Oral lipid-based formulations","volume":"59","author":"Hauss","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2011.05.009_b0010","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","article-title":"Nanosizing\u2013oral formulation development and biopharmaceutical evaluation","volume":"59","author":"Kesisoglou","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2011.05.009_b0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.addr.2007.05.010","article-title":"Salt formation to improve drug solubility","volume":"59","author":"Serajuddin","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2011.05.009_b0020","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.addr.2007.05.013","article-title":"Prodrug strategies to overcome poor water solubility","volume":"59","author":"Stella","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2011.05.009_b0025","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/js980403l","article-title":"Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs","volume":"88","author":"Serajuddin","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2011.05.009_b0030","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaceutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2011.05.009_b0035","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.addr.2007.05.011","article-title":"Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates","volume":"59","author":"Blagden","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2011.05.009_b0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jbiotec.2004.06.007","article-title":"Challenges and solutions for the delivery of biotech drugs \u2013 a review of drug nanocrystal technology and lipid nanoparticles","volume":"113","author":"Muller","year":"2004","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.ejpb.2011.05.009_b0045","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.addr.2007.05.004","article-title":"Lipid nanoparticles: perspectives and challenges","volume":"59","author":"Gasco","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2011.05.009_b0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2011.05.009_b0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2004.12.019","article-title":"Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method","volume":"293","author":"Takeuchi","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.05.009_b0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejpb.2005.08.013","article-title":"Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers","volume":"62","author":"Friedrich","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2011.05.009_b0065","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jconrel.2005.06.007","article-title":"Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization","volume":"107","author":"Jain","year":"2005","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejpb.2011.05.009_b0070","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/jps.10308","article-title":"Formation of physically stable amorphous drugs by milling with Neusilin","volume":"92","author":"Gupta","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2011.05.009_b0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2009.09.016","article-title":"Propranolol-magnesium aluminum silicate complex dispersions and particles: characterization and factors influencing drug release","volume":"383","author":"Rojtanatanya","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.05.009_b0080","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/smll.200700005","article-title":"Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs","volume":"3","author":"Lu","year":"2007","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2011.05.009_b0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpharm.2008.01.049","article-title":"Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport","volume":"357","author":"Mellaerts","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.05.009_b0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejpb.2007.11.006","article-title":"Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica","volume":"69","author":"Mellaerts","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2011.05.009_b0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejpb.2010.06.016","article-title":"Enhancement of dissolution rate and oral absorption of a poorly water-soluble drug, K-832, by adsorption onto porous silica using supercritical carbon dioxide","volume":"76","author":"Miura","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2011.05.009_b0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijpharm.2004.05.006","article-title":"pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A","volume":"280","author":"Dai","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.05.009_b0105","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2004.03.003","article-title":"Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration","volume":"97","author":"Wang","year":"2004","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejpb.2011.05.009_b0110","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1007\/s11095-008-9543-1","article-title":"Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption","volume":"25","author":"Miller","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2011.05.009_b0225","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/02652040903059163","article-title":"Effects of pH-sensitive nanoparticles prepared with different polymers on the distribution, adhesion and transition of Rhodamine 6G in the gut of rats","volume":"27","author":"Wu","year":"2010","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejpb.2011.05.009_b0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejps.2008.01.005","article-title":"A high-throughput approach towards a novel formulation of fenofibrate in omega-3 oil","volume":"33","author":"Ratanabanangkoon","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2011.05.009_b0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejpb.2007.05.010","article-title":"Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations","volume":"68","author":"Vogt","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2011.05.009_b0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1527-3466.2002.tb00098.x","article-title":"Update on fenofibrate","volume":"20","author":"Guay","year":"2002","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.ejpb.2011.05.009_b0135","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1345\/aph.18432","article-title":"Micronized fenofibrate: a new fibric acid hypolipidemic agent","volume":"33","author":"Guay","year":"1999","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejpb.2011.05.009_b0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/nano.2006.1.2.129","article-title":"Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review","volume":"1","author":"Tziomalos","year":"2006","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2011.05.009_b0145","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/jps.20754","article-title":"Factors affecting the formation of eutectic solid dispersions and their dissolution behavior","volume":"96","author":"Vippagunta","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2011.05.009_b0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2009.04.022","article-title":"Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt","volume":"376","author":"Chen","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.05.009_b0155","doi-asserted-by":"crossref","first-page":"E344","DOI":"10.1208\/aapsj0903041","article-title":"Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate","volume":"9","author":"Patel","year":"2007","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2011.05.009_b0160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejps.2008.01.005","article-title":"A high-throughput approach towards a novel formulation of fenofibrate in omega-3 oil","volume":"33","author":"Ratanabanangkoon","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2011.05.009_b0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2004.03.026","article-title":"Novel pH-sensitive supramolecular assemblies for oral delivery of poorly water soluble drugs: preparation and characterization","volume":"97","author":"Sant","year":"2004","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejpb.2011.05.009_b0170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2008.04.041","article-title":"Dissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxide","volume":"360","author":"Sanganwar","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.05.009_b0175","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/jps.21576","article-title":"IVIVC in oral absorption for fenofibrate immediate release tablets using a dissolution\/permeation system","volume":"98","author":"Buch","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2011.05.009_b0180","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.addr.2007.04.005","article-title":"Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug","volume":"59","author":"Hanafy","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2011.05.009_b0185","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1021\/ja01269a023","article-title":"Adsorption of gases in multimolecular layers","volume":"60","author":"Brunauer","year":"1938","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejpb.2011.05.009_b0230","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/ja01145a126","article-title":"The determination of pore volume and area distributions in porous substances. 1. Computations from nitrogen isotherms","volume":"73","author":"Barrett","year":"1951","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejpb.2011.05.009_b0195","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijpharm.2007.05.006","article-title":"Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design","volume":"342","author":"Vandecruys","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.05.009_b0200","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1021\/mp800042d","article-title":"Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole","volume":"5","author":"DiNunzio","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2011.05.009_b0205","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1208\/s12249-009-9186-5","article-title":"Physicomechanical properties of naproxen-loaded microparticles prepared from Eudragit L100","volume":"10","author":"Maghsoodi","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2011.05.009_b0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-5173(01)00776-1","article-title":"Stability of amorphous indomethacin compounded with silica","volume":"226","author":"Watanabe","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.05.009_b0215","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1517\/17425247.3.1.97","article-title":"Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs","volume":"3","author":"Gao","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2011.05.009_b0220","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1081\/DDC-120028718","article-title":"Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations","volume":"30","author":"Gao","year":"2004","journal-title":"Drug Dev. Ind. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111100169X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111100169X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T12:10:33Z","timestamp":1560255033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964111100169X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S093964111100169X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2011.05.009","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}